TRIM52 and ovarian carcinoma: Additional ZVAD experiments reduced the risk of spontaneous cells apoptosis mediated by knocking down TRIM52 and further verified the effectors of TRIM52 in promoting ovarian cancer cells invasion, migration, and proliferation.